For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Chong Kun Dang Corporation

USPTO Granted Patents = 23

Forward Citations = 373

Loading Chart...

Loading Chart...

74 inventors (with patents filed for the assignee):

Jung Woo Kim (16 out of 72 patents)

Kyeong Bok Min (7 out of 7 patents)

Hee Jong Shin (6 out of 12 patents)

4. Soon Kil Ahn (5 out of 10 patents)

5. Chung Il Hong (5 out of 8 patents)

6. Nam Hee Choi (5 out of 5 patents)

7. Hyoung Sik Chun (4 out of 4 patents)

8. Jung-Woo Kim (3 out of 25 patents)

9. Nam Song Choi (3 out of 4 patents)

10. Seung Kee Moon (3 out of 3 patents)

11. Byeong Seon Jeong (3 out of 3 patents)

12. Su Geun Yang (3 out of 3 patents)

13. Sang Joon Lee (3 out of 3 patents)

14. Chong Ryul Lee (3 out of 5 patents)

15. Hong Woo Lee (3 out of 3 patents)

23 patents: Sort by Forward Citations

1. 6608045 - Streptomyces sp producing tautomycetin and immunosuppressant comprising tautomycetin as active ingredient (2003-08-19),

2. 6310207 - Process of preparing camptothecin derivatives (2001-10-30),

3. 6306434 - Pharmaceutical composition comprising cyclosporin solid-state microemulsion (2001-10-23),

4. 6265413 - Camptothecin compounds and a method of preparation thereof (2001-07-24),

5. 6177568 - Intermediates for the synthesis of camptothecin derivatives (2001-01-23),

6. 6072051 - Nucleoside derivatives and process for preparing the same (2000-06-06),

7. 6063812 - Fumagillol derivatives and processes for preparing the same (2000-05-16),

8. 6063762 - Cyclosporin-containing microemulsion preconcentrate composition (2000-05-16),

9. 6048540 - Acetamenophen composition with reduced liver toxicity (2000-04-11),

10. 6040337 - 5-demethoxyfumagillol derivatives and processes for preparing the same (2000-03-21),

11. 6034087 - Nucleoside derivatives and process for preparing thereof (2000-03-07),

12. 6028067 - Cyclosporin-containing microemulsion preconcentrate composition (2000-02-22),

13. 5980939 - Cyclosporin-containing pharmaceutical composition (1999-11-09),

14. 5952461 - Process for preparing human proinsulin (1999-09-14),

15. 5925551 - Aspergillus genus showing resistance to cerulenin and L-methionine (1999-07-20),

Chong Kun Dang Corporation is a prominent South Korean pharmaceutical company headquartered in Seoul. The organization specializes in the development and manufacturing of a wide range of pharmaceutical products, including prescription medications and over-the-counter drugs. With a strong emphasis on research and development, Chong Kun Dang focuses on innovative solutions in therapeutic areas such as oncology, cardiology, and neurology. The company is committed to enhancing healthcare through advanced technologies and high-quality products, serving both domestic and international markets.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

23 Patents

#206 in Seoul

#569 in South Korea

#27,619 in the World

Seoul, South Korea

Chong Kun Dang Corporation

Forward Citations = 373

74 inventors:

Jung Woo Kim (16 out of 72 patents)

Kyeong Bok Min (7 out of 7 patents)

Hee Jong Shin (6 out of 12 patents)

4. Soon Kil Ahn (5 out of 10 patents)

5. Chung Il Hong (5 out of 8 patents)

Please report any incorrect information to [email protected]

Loading…